BC
Broadfin Capital Portfolio holdings
AUM
$403M
1-Year Return
74.97%
This Quarter Return
-8.43%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$883M
AUM Growth
-$170M
(-16%)
Cap. Flow
-$35.2M
Cap. Flow
% of AUM
-3.98%
Top 10 Holdings %
Top 10 Hldgs %
52.81%
Holding
75
New
10
Increased
19
Reduced
14
Closed
13
Top Buys
| 1 |
NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
|
$16.4M |
| 2 |
Veracyte
VCYT
|
$13.8M |
| 3 |
Heron Therapeutics
HRTX
|
$13.7M |
| 4 |
Teva Pharmaceuticals
TEVA
|
$12.6M |
| 5 |
BCR
CR Bard Inc.
BCR
|
$9.03M |
Top Sells
| 1 |
NVDQ
Novadaq Technologies Inc.
NVDQ
|
$33.8M |
| 2 |
AngioDynamics
ANGO
|
$23.9M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$18.9M |
| 4 |
Dynavax Technologies
DVAX
|
$14.1M |
| 5 |
AEGR
Aegerion Pharmaceuticals, Inc.
AEGR
|
$13M |
Sector Composition
| 1 | Healthcare | 90.7% |
| 2 | Financials | 0.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BDSI
26
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $9.45M | 1.05% |
5,398,794
+210,000
| +4% | +$368K |
|
|
ZGNX
27
DELISTED
Zogenix, Inc.
ZGNX
| $9.31M | 1.03% |
766,412
-115,900
| -13% | -$1.41M |
|
|
BCR
28
DELISTED
CR Bard Inc.
BCR
| $9.03M | 1% |
+40,200
| New | +$9.03M |
|
|
AMRN
29
Amarin Corp
AMRN
$311M
| $8.73M | 0.97% |
141,682
-26,270
| -16% | -$1.62M |
|
|
SPNE
30
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $8.69M | 0.96% |
1,100,007
| – | – |
|
31
Zimmer Biomet
ZBH
$20.8B
| $8.62M | 0.96% |
+86,005
| New | +$8.62M |
|
32
Catalyst Pharmaceutical
CPRX
$2.42B
| $8.61M | 0.96% |
8,200,000
| – | – |
|
|
ELGX
33
DELISTED
Endologix Inc
ELGX
| $8.58M | 0.95% |
150,000
+70,000
| +88% | +$4M |
|
|
CORI
34
DELISTED
Corium International, Inc.
CORI
| $7.79M | 0.87% |
1,919,721
| – | – |
|
|
SBBP
35
DELISTED
Strongbridge Biopharma plc.
SBBP
| $6.95M | 0.77% |
2,894,581
+1,237,875
| +75% | +$2.97M |
|
|
ACGN
36
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $6.64M | 0.74% |
32,590
+14,721
| +82% | +$3M |
|
37
Cidara Therapeutics
CDTX
$1.65B
| $5.85M | 0.65% |
28,144
+19,800
| +237% | +$4.12M |
|
38
ADMA Biologics
ADMA
$4.03B
| $5.7M | 0.63% |
1,113,293
| – | – |
|
39
Medtronic
MDT
$119B
| $5.34M | 0.59% |
+75,000
| New | +$5.34M |
|
40
Pacira BioSciences
PCRX
$1.2B
| $4.87M | 0.54% |
150,680
| – | – |
|
41
Glaukos
GKOS
$5.17B
| $4.85M | 0.54% |
+141,300
| New | +$4.85M |
|
42
SCYNEXIS
SCYX
$36.4M
| $4.71M | 0.52% |
147,727
| – | – |
|
43
Arcturus Therapeutics
ARCT
$455M
| $4.32M | 0.48% |
293,872
+1,379
| +0.5% | +$20.3K |
|
|
VXRT
44
DELISTED
Vaxart
VXRT
| $4.29M | 0.48% |
316,974
| – | – |
|
|
EGLT
45
DELISTED
Egalet Corporation
EGLT
| $4.26M | 0.47% |
556,233
-578,517
| -51% | -$4.43M |
|
|
NVET
46
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
| $4.21M | 0.47% |
1,127,200
+109,945
| +11% | +$410K |
|
|
MRTX
47
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.92M | 0.44% |
826,001
-173,999
| -17% | -$827K |
|
48
Tenax Therapeutics
TENX
$27.4M
| $3.84M | 0.43% |
62
| – | – |
|
|
NVRO
49
DELISTED
NEVRO CORP.
NVRO
| $3.15M | 0.35% |
43,281
-7,274
| -14% | -$529K |
|
50
MediWound
MDWD
$182M
| $2.9M | 0.32% |
90,443
+14,588
| +19% | +$468K |
|